Back to products
Klow: BPC 157 + GHK-CU + TB 500 + KPV
Klow: BPC 157 + GHK-CU + TB 500 + KPV Original price was: $ 200.Current price is: $ 160. - or subscribe

GLP1 – Semi

Price range: $ 110 through $ 190 - or subscribe

Disclaimer:

This product is designated solely as a research chemical for laboratory use. It is limited to in vitro studies and experimental research, with all website information provided for educational purposes only. Administration to humans or animals is prohibited by law. It is not a drug, food, or cosmetic and must not be misrepresented, improperly used, or mislabeled as such.

Choose frequency:

Add $ 200 to cart and get free shipping!

Quantity Price Discount
3-5 $ 106 4%
6-8 $ 101 8%
10-15 $ 98 11%
16+ $ 110 $ 0

Description

GLP-1 (GLP1 – Semi) Research Peptide

GLP-1 (Glucagon-Like Peptide-1) receptor agonist peptide is a highly studied compound in metabolic research, primarily focusing on blood sugar regulation, appetite control, and weight management. Supplied as a lyophilized vial, GLP1 – Semi is designed for in-vitro laboratory research, providing researchers with a reliable tool to study GLP-1 receptor pathways and metabolic mechanisms. This laboratory-grade peptide is available in 5 mg and 10 mg vial sizes, suitable for controlled experimental assays and biochemical studies.

Used widely in metabolic disorder research, GLP-1 peptides help scientists investigate cellular responses, hormone signaling, and receptor interactions related to glucose metabolism and energy balance. Please note, this product is strictly for research purposes only and is not intended for human or veterinary use. Researchers are advised to handle the peptide under proper laboratory safety protocols and follow all institutional guidelines for storage and disposal.

LiveWell Peptides ensures that GLP1 – Semi is high-purity, lyophilized, and tested for consistency, making it an ideal choice for metabolic and receptor pathway studies in the USA. This product enables precise in-vitro experimentation, supporting advancements in diabetes, obesity, and metabolic disorder research.

Reference Link: Click Here